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Abstract
Context—Air pollution exposure affects autonomic function, heart rate, blood pressure and left 
ventricular function. While the mechanism for these effects is uncertain, several studies have 
reported that air pollution exposure modifies activity of the carotid body, the major organ that 
senses changes in arterial oxygen and carbon dioxide levels, and elicits downstream changes in 
autonomic control and cardiac function.
Objective—We hypothesized that exposure to acrolein, an unsaturated aldehyde and mucosal 
irritant found in cigarette smoke and diesel exhaust, would activate the carotid body 
chemoreceptor response and lead to secondary cardiovascular responses in rats.
Materials and methods—Spontaneously hypertensive (SH) rats were exposed once for 3 h to 3 
ppm acrolein gas or filtered air in whole body plethysmograph chambers. To determine if the 
carotid body mediated acrolein-induced cardiovascular responses, rats were pretreated with an 
inhibitor of cystathionine γ-lyase (CSE), an enzyme essential for carotid body signal transduction.
Results—Acrolein exposure induced several cardiovascular effects. Systolic, diastolic and mean 
arterial blood pressure increased during exposure, while cardiac contractility decreased 1 day after 
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exposure. The cardiovascular effects were associated with decreases in pO2, breathing frequency 
and expiratory time, and increases in sympathetic tone during exposure followed by 
parasympathetic dominance after exposure. The CSE inhibitor prevented the cardiovascular 
effects of acrolein exposure.
Discussion and conclusion—Pretreatment with the CSE inhibitor prevented the 
cardiovascular effects of acrolein, suggesting that the cardiovascular responses with acrolein may 
be mediated by carotid body-triggered changes in autonomic tone. (This abstract does not reflect 
EPA policy.)
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Introduction
Multiple lines of evidence demonstrate that exposure to air pollution, including cigarette 
smoke, increases cardiovascular morbidity and mortality (Brook et al., 2010). Several 
mechanisms have been postulated that overlap among gaseous and particulate pollutants 
including vascular oxidative stress, endothelial dysfunction, inflammation and altered 
autonomic tone (Brook et al., 2010; Srebot et al., 2009). Changes in cardiac autonomic tone, 
when present, are often the most immediate consequences of air pollution exposure (Brook 
et al., 2010). We have previously shown that one of the more prominent autonomic reflex 
arcs involves pulmonary C fibers and is triggered by activation of the transient receptor 
potential channel A (TRPA; Hazari et al., 2011). Recent evidence suggests that some of the 
cardiovascular effects of air pollution may be mediated by a relatively unexplored neural 
reflex involving the carotid body, a major sensory organ located at the bifurcation of the 
carotid artery that initiates reflex responses to changes in pCO2, pO2, pH and temperature. 
Exposure to acrolein, an unsaturated aldehyde and mucosal irritant found in cigarette smoke 
and diesel exhaust, reduces arterial pO2, suggesting that downstream effects of air pollutants 
may be controlled by carotid chemoreceptor responses (Janssens et al., 1994). Several 
epidemiological studies have reported small changes in oxygen saturation in human subjects 
with exposure to air pollution (DeMeo et al., 2004; Gong et al., 2004; Pope et al., 1999). 
Furthermore, human exposures to ambient levels of the air pollutants tobacco smoke 
(Adgent, 2006), SO2 and NO2 (Hoppenbrouwers et al., 1981) were linked to abnormal 
cardiopulmonary responses to hypoxia, indicating modified carotid activity. Despite such 
associations, a direct link between the carotid body and air pollution-induced adverse 
cardiovascular effects has not been established.
Activation of the carotid body triggers changes in autonomic tone that cause reflex 
cardiopulmonary changes to maintain homeostasis. In response to hypercapnia/hypoxia, for 
example, the carotid body triggers increases in sympathetic tone that in turn cause elevations 
in blood pressure (BP), ventilation and heart rate (HR) (Liu et al., 2003; Lopez-Barneo et al., 
2008; Roux et al., 2000). Such shifts in autonomic tone may, however, be detrimental. For 
example, low heart rate variability (HRV), indicating increased sympathetic tone, is 
associated with elevated cardiovascular risk, including increased mortality rate in people 
with heart disease (Fauchier et al., 2004). Low HRV has also been reported with exposure to 
Perez et al. Page 2













PM and ozone (Brook et al., 2010). Parallels between carotid body-mediated effects and 
cardiovascular responses associated with air pollution exposure suggest a linkage is 
plausible.
Recently, we found that exposure to 3 ppm acrolein causes apnea (Hazari et al., 2008), 
increases BP and modifies responses to a hypoxia stress test in rats (Perez et al., 2013). In 
addition, Wang et al. (2012) demonstrated that cardiac arrhythmias occurring in heart failure 
mice after intratracheal instillation with 20 mg/kg ambient particulates were associated with 
altered carotid body sensitivity. These findings suggest that the carotid body might mediate 
cardiac and vascular effects of air pollution exposure. The purpose of this study was to 
determine if the cardiovascular effects of acrolein inhalation were mediated by carotid body 
activation. We hypothesized that: (1) exposure to acrolein will alter arterial blood gas levels 
in spontaneously hypertensive rats, a strain with exaggerated sensitivity to acrolein (Perez et 
al., 2013) and (2) inhibition of carotid body sensing will prevent the cardiovascular 
responses to acrolein exposure. Carotid body sensing was blocked by pretreatment with an 
inhibitor of the H2S-generating enzyme cystathionine γ-lyase (CSE), which is essential for 
carotid body signal transduction (Peng et al., 2010). Blood gases, respiratory parameters, 
HR, blood pressure and HRV were monitored before, during and after exposure. In addition, 
left ventricular pressure, cardiac contractility and lusitropy were assessed before and after 
vagotomy 1 day after acrolein exposure.
Materials and methods
Drugs
The cystathionine γ-lyase enzyme (CSE) inhibitor DL-propargylglycine (PAG) was obtained 
from Sigma (St. Louis, MO; 200 mg/kg) and was administered intraperitoneally (i.p.) 
immediately before exposures. Dose and drug administration were determined in previous 
work by Peng et al. (2010). All solutions with drugs were prepared fresh before every 
experiment. Rats not treated with DL-propargylglycine (PAG) were treated with an 
equivalent volume of saline administered intraperitoneally immediately before exposures.
Animals
Twelve-week-old male spontaneously hypertensive (SH) and Wistar Kyoto (WKY) rats with 
normal blood pressure (Charles River, Raleigh, NC) were housed in plastic cages (one per 
cage), maintained on a 12-h light/dark cycle at approximately 22 °C and 50% relative 
humidity in our AAALAC approved facility, and held for a minimum of 1 week before 
exposure. Food (Prolab RMH 3000; PMI Nutrition International, St. Louis, MO) and water 
were provided ad libitum, and all rats were randomized by weight. SH rats were divided into 
one of three cohorts: (1) rats implanted with femoral artery catheters to enable serial arterial 
blood draws to monitor blood gases and analytes before, during and after acrolein exposure 
in conscious, unrestrained rats, (2) rats implanted with radio-telemeters and studied in whole 
body plethysmographs to monitor blood pressure, HR and ventilation parameters before, 
during and after acrolein exposure and (3) rats that underwent left ventricular pressure 
assessments 1 day after acrolein exposure before and after vagotomy. A cohort of WKY rats 
was also implanted with femoral artery catheters to assess the impact of acrolein exposure 
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on arterial blood gases. WKY rats were not included in additional assessments due to the 
absence of cardiovascular responses during acrolein exposure in previous studies (Perez et 
al., 2013). After all experiments were performed, rats were deeply anesthetized with an 
intraperitoneal injection of Euthasol (200 mg/kg Na pentobarbital and 25 mg/kg phenytoin; 
Virbac Animal Health, Fort Worth, TX) and euthanized by exsanguination. The IACUC of 
the U.S. Environmental Protection Agency (US EPA) approved all protocols.
Telemeter and catheter implantation
SH rats were implanted with radiotelemetry transmitters to monitor HR, blood pressure (BP) 
and heart rhythm (Model TL11M2-C50-PXT; Data Science International, Inc., St. Paul, 
MN) as previously described (Perez et al., 2013). Animals were allowed approximately 2 
weeks to recover prior to exposures. A separate cohort of SH (n = 20) and WKY (n = 5) rats 
were implanted with femoral artery catheters in accordance with methods specified by the 
vendor (Charles River Laboratories, 2005). Animals were shipped to the US EPA within 1 
week of surgery. The catheters were flushed with saline, locked with heparin and plugged 
immediately upon arrival and every 2 days thereafter until exposure began.
Acrolein exposure
Rats implanted with telemeters were acclimated to exposure chambers daily for 1 h 
beginning 2 days before exposure. All rats were assigned to one of four treatments groups (n 
= 6/group): air exposure with saline pretreatment; acrolein exposure with saline 
pretreatment; air exposure with PAG pretreatment; and acrolein exposure with PAG 
pretreatment. On the exposure day, rats were pretreated via intraperitoneal injection of saline 
or PAG and then allowed to acclimate to the chambers for 30 min. Baseline data were 
recorded for the next 30 min. All exposures took place in whole body plethysmography 
chambers (WBP; Model PLY3213, Buxco Electronics, Inc, Wilmington, NC), which 
continuously and non-invasively monitor ventilatory parameters in conscious animals. SH 
rats were exposed to filtered air or 3 ppm acrolein for 3 h. Acrolein gas was metered from a 
1000-ppm cylinder into a glass mixing chamber where the gas was mixed with dry filtered 
dilution air to achieve a final concentration of 3 ppm of acrolein with a total flow of 6 L/
min. The actual chamber concentration was measured by injection of a batch sample every 
10 min into an HP5890 gas chromatograph (GMI Inc., Ramsey, MN) equipped with manual 
injection, a flame ionization detector and a DB-VRX capillary column. All control rats were 
exposed to dry filtered dilution air only. The plethysmograph pressure was monitored using 
Biosystems XA software (Buxco Electronics, Inc, Wilmington, NC). Using respiratory-
induced fluctuations in ambient pressure, respiratory parameters including tidal volume, 
breathing frequency, inspiratory time and expiratory time were calculated and recorded on a 
breath-by-breath basis and averaged over 10 s intervals. HR, systolic and diastolic BP, ECG 
waveforms and ventilatory data were collected during the exposure, and animals were 
returned to their home cages after exposure. The concentration of acrolein (3 ppm) used in 
this study is representative of concentrations in high-combustion areas (Hazari et al., 2008). 
Acrolein concentrations ranging from 10 to 140 μg/cigarette have been found in mainstream 
smoke and concentrations ranging from 100 to 1700 μg/cigarette have been found in side-
stream smoke (Jones, 1999). In addition, Sakaguchi et al. (2014) found acrolein levels of 
47.10 μg/cigarette after urine analysis of Japanese males who smoke conventional cigarettes.
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Arterial blood gas analysis during acrolein exposure
Changes in blood gas parameters during acrolein exposure were determined in a separate 
cohort of rats. Rats implanted with femoral artery catheters were acclimated to whole body 
plethysmography chambers (WBP; Model PLY3213, Buxco Electronics, Inc, Wilmington, 
NC), 1 h on the 2 days prior to exposure. On the day of exposure, the rats received an 
intraperitoneal injection of either saline or PAG. The exteriorized jugular vein catheter was 
extended with a 1-mL PE50 catheter attached to a 23-gauge adapter traversing a hole in the 
wall of the plethysmograph and allowing blood draws outside of the sealed exposure 
chamber. Rats were acclimated to the exposure chambers for 30 min and then were exposed 
to either filtered air or acrolein. For all exposure groups, a baseline 250-μL blood sample 
was taken after acclimation followed by serial 250 μL blood draws at 30 min after baseline, 
1 h after baseline and 1 h 15 min after baseline. For each blood draw, the pin was removed 
from the tip of the catheter, and the heparin was allowed to exit the catheter. When only 
blood remained, a 23-gauge adapter attached to a 1-mL syringe was placed on the end of the 
catheter and used to draw a 250-μL sample. The blood sample was immediately read on an 
OPTI CCA-TS Blood Analyzer (OPTI Medical Systems, Inc., Roswell, GA) using the OPTI 
Cassette E-Ca which measures blood pH, PCO2, PO2, Na+, K+, Ca2+, total hemoglobin 
(tHb), oxygen saturation (SaO2) and hematocrit (Hct). The catheter was flushed with saline 
and locked with heparin after each blood draw.
Ventilatory monitoring during exposure
All exposures were performed in whole-body plethysmography chambers (Buxco 
Electronics, Sharon, CT). The plethysmography methodology permitted continuous 
monitoring of breathing frequency, tidal volume, minute volume, inspiratory time and 
expiratory time as described in Perez et al. (2013).
Cardiovascular monitoring during exposure
Radiotelemetry methodology (Data Sciences International, Inc., St. Paul, MN) enabled 
constant monitoring of ECG data in unrestrained, un-anesthetized rats from implantation 
until euthanasia as described in Perez et al. (2013).
Heart rate variability analysis
ECGAuto software (EMKA Technologies, Falls Church, VA) was used for automated 
analysis of heart rate variability (HRV). Arrhythmias, artifacts and ECG waveforms lacking 
distinguishable R waves for more than 30 s were identified and excluded. The analysis of 
HRV generated HR and time-domain measures, including mean time between adjacent QRS 
complex peaks (the RR interval), a standard deviation of the RR interval (SDNN), SDNN 
normalized for the effects of HR [SDNN/(RR interval × 100)] and the square root of the 
mean of squared differences of adjacent RR intervals (RMSSD). The SDNN represents 
overall HRV, whereas RMSSD represents parasympathetic influence over HR. The analysis 
of HRV also calculated frequency-domain parameters, particularly low-frequency (LF) and 
high-frequency (HF), and the ratio of these two frequency-domains (LF/HF). LF is generally 
believed to represent a mixture of sympathetic and parasympathetic tone, whereas HF 
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indicates cardiac parasympathetic (vagal) tone, and LF/HF serves as an index of 
sympathovagal balance.
Left ventricular pressure 24 hours after exposure
A third cohort of rats exposed to filtered air or acrolein with or without PAG pre-treatment 
underwent left ventricular pressure (LVP) assessments to measure cardiac function 24 h 
after exposure. Rats were anesthetized with urethane (1.5 mg/kg i.p., Sigma) and prepared 
for LVP measurement by right carotid arterial catheterization with a 2-French transducer 
(SPR-320, Millar Instruments, Houston, TX). The LV probe was connected via a Pressure 
Control Unit (Model 2000, Millar Instruments) to a receiver (Powerlab 4/30, 
ADInstruments, Dunedin, New Zealand) and a computer acquiring data at 1000 Hz. The 
probe was advanced into the LV for a 5-min baseline. To assess the role of parasympathetic 
tone in the response to acrolein, rats that were pretreated with saline alone underwent 
bilateral vagotomy by ligating both vagus nerves. Acquisition software (LabChart Pro 
version 7.3.2, AD Instruments) generated pressure at end diastole and end systole (EDP and 
ESP) and the maximum and minimum pressure slopes (dP/dtmax and dP/dtmin, respectively) 
per beat, indicative of contractility and relaxation rate (lusitropy), respectively.
Statistics
For the statistical analyses of the Buxco, ECG and HRV data in this study, we used SAS 
version 9.2 software (SAS Institute Inc, Cary, NC). PROC MIXED of SAS was used 
because of its greater flexibility for the modeling of repeated measures data when compared 
to PROC GLM. It is also suitable for analysis of large, unbalanced data with missing data at 
random. A linear mixed model with restricted maximum-likelihood estimation analysis, 
least squares means and repeated measures ANOVA was used to determine which TIME × 
TRT interactions were statistically significant between baseline and exposure. Multiple 
comparison adjustment for the p values and confidence limits for the differences between 
the least squares means was done using adjust = Tukey HSD (honest significant difference) 
test. All blood gas data were analyzed using GraphPad Prism (GraphPad Software, Inc., La 
Jolla, CA) with a one-way analysis of variance (ANOVA) model examining the main effects 
of each model.
Results
Effects of acrolein on arterial blood gases
For all acrolein exposures, the average chamber concentration of acrolein was 2.9 ± 0.1 
ppm.
In rats exposed to acrolein and pretreated with saline, pO2 decreased from baseline levels of 
101.4 ± 1.7 to 91.0 ± 3.6 mmHg 30 min into exposure, to 90.2 ± 1.2 mmHg 1 h into 
exposure, and to 89.8 mmHg 15 min after exposure ended (p<0.05; Figure 1A). pCO2 
increased from baseline levels of 38.6 ± 1.2 to 41.9 ± 1.4 mmHg 30 min into exposure, to 
42.0 ± 1.6 mmHg 1 h into exposure, and remained high at 41.8 ± 1.4 mmHg 15 min after 
exposure ended (p<0.05; Figure 1B). Rats exposed to acrolein and pretreated with saline had 
significant decreases in K+ during and after exposure. Baseline K+ levels of 6.6 ± 0.7 
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mmol/L decreased to 4.4 ± 0.2 30 min into exposure, to 4.6 ± 0.4 1 h into exposure, and 
increased slightly to 5.5 ± 0.5 mmol/L after exposure ended (p<0.05; Figure 1C). There 
were no effects of PAG pretreatment on acrolein-induced changes in pO2, pCO2, or K+.
SaO2, Na+ and pH were not affected by acrolein exposure or PAG pretreatment (data not 
shown). WKY rats exposed to air or acrolein had no changes in any blood parameters 
measured (Table 1).
Effects of acrolein on ventilatory parameters
Breathing frequency decreased in rats exposed to acrolein in the first 30 s of exposure. 
Breathing frequency decreased from 288 ± 23 breaths/min at baseline to 153 ± 15 
breaths/min 20 s into acrolein exposure (p<0.05; Figure 2A). In addition, acrolein exposed 
rats had significant increases in expiratory time (Te), a measure of apnea, within the first 20 
s of exposure. Te increased from baseline levels of 0.2 ± 0.03 s to 0.3 ± 0.03 s at 10 s into 
acrolein exposure and 0.3 ± 0.02 s 20 s into acrolein exposure (p<0.05; Figure 2B). Te 
returned to normal levels after the first 20 s of exposure. Acrolein exposure caused a 
decrease in minute ventilation, although it was not statistically significant. PAG treatment in 
control and acrolein exposed rats had no effect on this parameter (data not shown). There 
were no significant changes in minute volume, tidal volume or inspiratory time in acrolein 
exposed rats treated with saline or PAG (data not shown).
Effects of acrolein on cardiovascular responses
Control rats exposed to air and pretreated with saline had gradual decreases in systolic blood 
pressure, diastolic blood pressure, HR and temperature during exposure (Figure 3), a 
common and expected response as the animals acclimate to the chamber. Rats were 
acclimated to exposure chambers for 1 h once per day beginning 2 days before exposure. On 
exposure day, rats were allowed to acclimate for 30 min before the 30-min baseline was 
recorded. Even with multiple acclimation periods, it is normal for blood pressure and HR to 
continue to decrease even 3 h after the beginning of exposure in control rats exposed to 
filtered air.
At hour 2, rats exposed to acrolein and pretreated with saline had a smaller decrease in 
systolic blood pressure than corresponding air-exposed and saline pretreated rats (3.3 ± 
2.0% versus 12.0 ± 2.0% decrease from respective baselines; p<0.05; Figure 3A). 
Pretreatment with PAG prevented the systolic blood pressure response to acrolein during 
hour 2 of exposure. At hour 3, rats exposed to acrolein and pretreated with saline had a 14.0 
± 2.2% increase from baseline compared to rats exposed to air and pretreated with saline 
that had a 10.0 ± 3.0% decrease from baseline (p<0.05). The systolic blood pressure 
response to acrolein during exposure hour 3 was also blocked with pretreatment with PAG.
At hour 3, diastolic blood pressure in rats exposed to acrolein and pretreated with saline had 
a 13.1 ± 3.0% increase from baseline compared to rats exposed to air and pretreated with 
saline who had a 14.0 ± 4.0% decrease from baseline (p<0.05; Figure 3B). The diastolic 
blood pressure response to acrolein during exposure hour 3 was blocked with pretreatment 
with PAG.
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At hour 2, rats exposed to acrolein and pretreated with saline had a smaller decrease in mean 
arterial blood pressure (MAP) than corresponding air-exposed and saline pretreated rats (4.0 
± 1.3% versus 13.1 ± 2.0% decrease from respective baselines; p<0.05; data not shown). 
The MAP response to acrolein during exposure hour 2 was blocked with pretreatment with 
PAG. At hour 3, rats exposed to acrolein and pretreated with saline had a 13.4 ± 2.5% 
increase from baseline compared to rats exposed to air and pretreated with saline that had an 
11.3 ± 3.4% decrease from baseline (p<0.05; data not shown). The MAP response to 
acrolein during exposure hour 3 was also blocked with pretreatment with PAG. Raw values 
for mean arterial, systolic and diastolic blood pressure are reported in Table 2.
HR did not change during exposure regardless of exposure group or PAG pretreatment 
(Figure 3C).
Core body temperature (Tco) decreased from baseline levels of 38.5 ± 0.1 °C to 37.6 ± 0.2 
°C at hour 2 (Figure 3D) in rats exposed to acrolein and pretreated with saline compared to 
rats exposed to and pretreated with saline that had decreases from 38.6 ± 0.2 °C at baseline 
to 37.3 ± 0.2 °C (p<0.05). The Tco response to acrolein during exposure hour 2 was also 
blocked with pretreatment with PAG.
PAG treatment alone did not affect MAP, systolic blood pressure, diastolic blood pressure, 
HR or Tco.
Effects of acrolein on HR variability
Rats exposed to acrolein and pretreated with saline had a significant decrease in the SDNN 
component of HRV during exposure (averaged over the entire exposure period; Figure 4A). 
SDNN decreased from baseline values of 5.7 ± 0.8 ms to 2.2 ± 0.2 ms during exposure 
(p<0.05; Figure 4A). Pretreatment with PAG prevented this acrolein-induced decrease in 
SDNN during exposure.
Rats exposed to acrolein and pretreated with saline had a significant decrease in the RMSSD 
component of HRV during exposure (averaged over the entire exposure period; Figure 4B). 
RMSSD decreased from baseline values of 6.3 ± 1.4 ms to 2.4 ± 0.3 ms during exposure 
(p<0.05). Pretreatment with PAG prevented this acrolein-induced decrease in RMSSD 
during exposure.
Rats exposed to acrolein and pretreated with saline had a significant increase in the LF 
component of HRV during exposure (averaged over the entire exposure period; data not 
shown). LF increased from baseline values of 0.4 ± 0.1 ms to 1.0 ± 0.1 ms during exposure 
(p<0.05). Pretreatment with PAG prevented this acrolein-induced increase in LF during 
exposure. There were no significant changes in the HF or LF/HF components of HRV 
during acrolein exposure (data not shown).
Effects of acrolein on left ventricular pressure
Rats exposed to acrolein and pretreated with saline had a significant decrease in dP/dtmax, a 
measure of cardiac contractility, 24 h after exposure compared to the control air exposure 
pretreated with saline. Rats exposed to acrolein and pretreated with saline had dP/dtmax 
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levels of 5,672.6 ± 630.6 mmHg/s compared to rats exposed to air and pretreated with saline 
(8992.4 ± 971.4 mmHg/s) (p<0.05; Figure 5A). This decrease was prevented with PAG 
pretreatment (Figure 5A). The acrolein-induced decrease in dP/dtmax was also reversed with 
bilateral vagotomy (Figure 5B).
Discussion and conclusions
The current study demonstrates four key findings: (1) acrolein exposure-induced apnea is 
associated with decreases in arterial pO2 and increases in pCO2, (2) arterial blood gas 
changes were evident in acrolein-exposed SH rats, but not in normotensive WKY rats, (3) 
acrolein-induced cardiovascular responses were associated with an autonomic pattern 
characterized by an early increase in sympathetic tone followed by parasympathetic 
dominance and (4) acrolein-induced cardiovascular responses that included changes in blood 
pressure, core body temperature, HR variability and cardiac contractility were prevented by 
pharmacologic blockade of the carotid body, the hypoxia- and hypercapnia-sensing organ.
Acrolein exposure decreased pO2 in hypertensive rats, consistent with the apneic response 
observed. Acrolein, like other environmental pollutants, stimulates airway irritant sensory 
nerves (Lee et al., 1992; Oortgiesen et al., 2000), especially chemosensitive 
bronchopulmonary C-fibers, in part by activation of transient receptor potential vanilloid 1 
cation channels (TRPV1) present on the peripheral terminals of these fibers (Hazari et al., 
2008). Upon activation of these fibers, a chemoreflex is elicited which is characterized by 
apnea and bronchospasm (Coleridge & Coleridge, 1994), which in part may explain the 
responses observed. We found decreases in breathing frequency in SH rats immediately after 
the start of acrolein as well as increases in expiratory time, a marker of apnea, consistent 
with our previous findings (Hazari et al., 2008). While this may explain the initial drop in 
pO2, the apneic response was transient, lasting only 30 s. Thus, apnea alone likely does not 
explain the decrease in pO2 that was detected up to an hour into exposure and that persisted 
for 30 min after a 1-h exposure to acrolein. Although we did not assess pulmonary 
histopathology or measure proinflamatory biomarkers, inflammation and tissue edema that 
are common at higher acrolein concentrations might have played a role. Janssens et al. 
(1994) reported decreases in arterial pO2 after acrolein smoke exposure in sheep and 
attributed the responses to acrolein-induced airway resistance and edema. Acrolein exposure 
also increases lung lymph flow and extracellular lung water coupled with airway damage 
and pulmonary edema (Hales et al., 1992). While acrolein exposure decreased pO2 in SH 
rats, no such change was evident in similarly exposed WKY rats and may be related to 
underlying differences in sensitivity to air pollution that relate to hypertension or other 
characteristics unique to the SH strain. Previous studies have shown that the SH rat responds 
with greater airway inflammation, edema and injury after air pollution exposure than WKY 
rats (Farraj et al., 2009). In addition, SH rats have larger carotid bodies (Habeck et al., 1985) 
and are more sensitive to the effects of hypoxia as evidenced by increased carotid sinus 
nerve activity and intracellular Ca2+ changes (Weil et al., 1998).
Although there were significant reductions in pO2 with acrolein exposure in SH rats, there 
were no significant changes in arterial blood oxygen saturation (i.e. SaO2). pO2 is a measure 
of dissolved oxygen in plasma, while SaO2 measures the percentage of hemoglobin sites 
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bound with O2. The discrepancy in pO2 and SaO2 is due to the fact that SaO2 is well 
buffered from rapid decreases due to the sigmoidal oxy-hemoglobin dissociation curve 
(Urbano & Mohsenin, 2006). The carotid body responds to changes in pO2, not SaO2, 
making pO2 the relevant indicator of a pollutant’s effect on the carotid body. Decreases in 
arterial pO2 were also coupled with increases in pCO2, potentially owing to changes in gas 
exchange since minute ventilation did not change significantly. Importantly, the body is 
significantly more sensitive to systemic changes in pCO2, and the magnitude of the change 
in pCO2 with acrolein exposure in this study has been demonstrated to be sufficient to 
trigger activation of the carotid body (Iturriaga et al., 2005). Increases in pCO2 as small as 5 
mmHg activate the carotid body (Whipp, 1994), suggesting that the carotid body may have 
been impacted to a greater extent by acrolein-induced increases in pCO2. Thus, while direct 
assessments of carotid body nerve activity were not made in this study, the small but 
significant decrease in pO2 and the larger increase in pCO2 suggest that carotid body 
activation took place. In addition, acrolein exposure reduced serum K+ concentration in 
hypertensive rats, although baseline concentrations were high in all exposure groups. Stress 
has been shown to rapidly increase K+ levels (Struthers et al., 1988), and potential stress 
induced by the chamber and blood draws in conscious and unrestrained animals may explain 
high-baseline K+ levels.
Acrolein-induced blood pressure and temperature changes may be related to early decreases 
in arterial pO2 and increases in pCO2, as has been demonstrated in other studies. For 
example, acute exposure of humans to low O2 tension at high altitude increases systemic 
arterial blood pressure and precipitates acute mountain sickness (Rhodes et al., 2011). Also, 
cats exposed to short-term anoxia had decreased pO2 and increased pCO2 coupled with 
increases in arterial blood pressure (Yang et al., 1992). In addition, acrolein exposure-
induced decreases in pO2 in sheep were accompanied by increases in pulmonary arterial 
pressure and pulmonary vascular resistance (Janssens et al., 1994). Acrolein exposure 
caused an increase in the LF component of HRV, an indicator of both sympathetic and 
parasympathetic autonomic nervous system activity (Rowan et al., 2007) and a decrease in 
SDNN and RMSSD, indicators of parasympathetic tone. Furthermore, acrolein exposure 
resulted in an immediate increase in body temperature and a decrease in cardiac contractility 
1 day after exposure compared to control animals. Although the reason for this finding is 
uncertain, sympathetic activation has been shown to increase body temperature by 
stimulating vasoconstriction (Constanzo, 2006). Exposure to acrolein in mice has been 
shown to cause inflammation and dilated cardiomyopathy characterized by contractile 
dysfunction (decreased dP/dtmax) and impaired relaxation (Ismahil et al., 2001). Although 
the early response to acrolein exposure was characterized by an increase in sympathetic 
tone, the decrease in contractility 1 day after acrolein exposure was mediated by vagal input, 
as evidenced by reversal with bilateral vagotomy. This shift in autonomic tone is consistent 
with vagal rebound, often following stressful encounters, including psychological stress 
(Mezzacappa et al., 2001) that drive a sympathetic response.
Pharmacological inhibition of carotid body signal transduction prevented acrolein-induced 
increases in blood pressure, body temperature and reductions in HR variability during 
exposure and the reduction in cardiac contractility 1 day after exposure. These results are in 
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parallel with the alterations in arterial blood gases and the associated apneic responses, and 
are in combination suggest a significant role for the carotid body. These findings are also 
consistent with the recent work by Wang et al. (2012), who demonstrated that cardiac 
arrhythmias in particulate-exposed heart failure mice were in part due to altered sensitivity 
of the carotid body. Furthermore, exposures to the air pollutants tobacco smoke (Adgent, 
2006), SO2 and NO2 (Hoppenbrouwers et al., 1981) were linked to abnormal 
cardiopulmonary sensitivity responses to hypoxia. Although cardiovascular responses of 
acrolein are likely also influenced by irritant and inflammatory mechanisms, the findings 
suggest a model whereby exposure to air pollution initiates a pathologic sequelae triggered 
by alterations in arterial blood gases. These alterations in turn activate carotid body-initiated 
autonomic reflexes that then alter cardiovascular function (Figure 6).
Although the acrolein concentration used in the present study was comparable to levels 
found in side-stream tobacco smoke and high-combustion areas, it would be important to 
examine effects at lower concentrations that are near levels found in ambient air. In addition, 
these studies should be performed with other environmentally relevant air pollutants 
including ambient particulate matter, ozone and diesel exhaust both in acute and chronic 
exposure settings. Moreover, this study was limited by the absence of direct measurement of 
carotid body nerve activity. Although Peng et al. (2010) showed that carotid body nerve 
activity was significantly inhibited by PAG at the concentration used in the present study, 
similar measurements would have directly confirmed the efficacy of PAG.
The present findings nevertheless demonstrate for the first time that acrolein exposure may 
mediate changes in blood pressure and cardiac function through carotid body chemo-
receptor signaling. Exposure to this well-characterized pulmonary irritant known to elicit 
apnea also affected blood gas concentrations and stimulated chemoreceptor activation with 
downstream physiological heart and vascular effects, likely mediated by reflex changes in 
autonomic tone. Taken together, these findings shed new light on the unexplored role of 
carotid signaling during air pollution exposure and reveal the complex interplay between 
chemoreceptor signaling, the autonomic nervous system and the regulation of heart rhythm, 
vascular control and blood pressure.
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Acrolein exposure causes significant decreases in arterial blood oxygen and potassium, and 
significant increases in arterial carbon dioxide. SH rats implanted with femoral artery 
catheters were injected with saline or PAG carotid body inhibitor, and exposed to 3 ppm 
acrolein or air control. Panels A, B and C refer to pO2, pCO2 and K+, respectively, measured 
at baseline, 30 min into acrolein exposure, 1 h into acrolein exposure and 15 min post-
exposure. Means and standard errors are reported. Significant differences from baseline 
values (p<0.05) are denoted with an asterisk.
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Acrolein exposure causes transient apnea immediately after the beginning of exposure. 
Panels A and B refer to breathing frequency and expiratory time during the first 30 s of 
acrolein exposure, respectively. Means and standard errors are reported. Significant 
differences from baseline values (p<0.05) are denoted with an asterisk.
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Carotid body inhibition attenuates acrolein-induced increases in blood pressure and core 
body temperature. Panels A, B, C and D refer to systolic blood pressure, diastolic blood 
pressure, heart rate and core body temperature, respectively, at each hour of exposure. 
Means and standard errors are reported. Significant differences between exposure groups 
(p<0.05) are denoted with an asterisk.
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Carotid body inhibition attenuates acrolein-induced increases in SDNN and RMSSD. Panels 
A and B refer to averaged baseline and exposure values for SDNN and RMSSD, 
respectively, for all groups. Means and standard errors are reported. Significant differences 
between baseline and exposure (p<0.05) are denoted with an asterisk.
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Carotid body inhibition reverses acrolein-induced decreases in dP/dtmax, a measure of 
contractility, 24 h post-acrolein exposure. Bilateral vagotomy reverses the acrolein-induced 
decrease in dP/dt. Panel A refers to baseline values of dP/dtmax 24 h post-exposure. Panel B 
refers to pre- and post-vagotomy values of dP/dtmax 24 h post-exposure. Means and standard 
errors are reported. Significant differences between groups (p<0.05) are denoted with an 
asterisk.
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The carotid body plays a role in mediating acrolein-induced cardiovascular dysfunction.
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Table 2
Raw values for mean arterial, systolic and diastolic blood pressure in SH rats.
Air + Saline Acrolein + Saline Air + PAG Acrolein + PAG
Mean arterial blood pressure (mmHg)
 Baseline 159.2 ± 5.7 151.9 ± 3.4 164.0 ± 5.4 156.7 ± 7.6
 Exposure hour 1 148.5 ± 7.9 148.8 ± 3.0 159.6 ± 4.2 156.4 ± 5.9
 Exposure hour 2 138.0 ± 4.3 145.7 ± 2.5 155.0 ± 5.1 150.6 ± 8.6
 Exposure hour 3 140.4 ± 2.3 171.9 ± 1.5 157.6 ± 5.2 158.4 ± 9.0
Systolic blood pressure (mmHg)
 Baseline 187.5 ± 5.6 179.1 ± 3.6 193.3 ± 6.0 188.4 ± 7.7
 Exposure hour 1 176.2 ± 8.3 176.5 ± 3.0 188.8 ± 4.4 187.3 ± 5.6
 Exposure hour 2 164.8 ± 5.0 173.0 ± 2.0 184.6 ± 5.5 181.4 ± 8.0
 Exposure hour 3 168.5 ± 2.2 203.6 ± 1.9 187.9 ± 5.8 191.7 ± 8.9
Diastolic blood pressure (mmHg)
 Baseline 132.2 ± 5.0 125.2 ± 2.8 135.5 ± 5.0 127.2 ± 7.4
 Exposure hour 1 122.4 ± 6.8 122.3 ± 3.2 130.3 ± 3.9 126.3 ± 5.6
 Exposure hour 2 112.2 ± 3.1 118.9 ± 3.1 125.4 ± 4.8 120.3 ± 8.8
 Exposure hour 3 113.1 ± 2.4 141.4 ± 2.1 127.6 ± 4.6 126.0 ± 8.9
Means and standard errors are reported.
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